Paying attention to the indicators of CRP, D-dimer, and CK-MB in patients and providing relevant symptomatic treatment as early as possible can improve patient prognosis and reduce the risk of death among COVID-19 patients with underlying cardiovascular diseases. The gene discussed is CRP; the disease is COVID-19.